Top HHS research and development in nanotechnology contractors (NAICS 541713)
- Latest 12 months
- $29.6M
- Net obligations · Up $2.7M vs. $26.9M preceding
- Prime contractors
- 4
- With positive obligations in the latest 12 months
Research the HHS federal contracting market for research and development in nanotechnology under NAICS 541713. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and potential recompete research leads.
Contract obligation trends for Research and Development in Nanotechnology at the Department of Health and Human Services
Federal records show $232.2M in net obligations across 99 awards in Research and Development in Nanotechnology at the Department of Health and Human Services from Oct 1, 2021 through Sep 10, 2026. This market accounts for 0.16% of $145.5B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 10.1% from $26.9M to $29.6M. 1 prime contractor accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Sep 10, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $70.8M | 94 | Complete |
| FY2023 | $62.3M | 69 | Complete |
| FY2024 | $42.6M | 54 | Complete |
| FY2025 | $27.2M | 46 | Complete |
| FY2026 | $29.3M | 32 | YTD through Sep 10, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $232.2M
- 99 awards · 49 prime contractors
- Latest 12-month movement
- +10.1%
- $29.6M vs. $26.9M
- Leading eight prime share
- 100.0%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 0.16% of $145.5B in agency-wide net obligations.
- Set-aside share when reported
- 7.2% of 69 awards with reported set-aside status.
- Set-aside reporting
- 5 set aside · 64 no set-aside · 30 not reported
What changed in the last 12 months?
Sep 11, 2025–Sep 10, 2026, compared with Sep 11, 2024–Sep 10, 2025.
Market structure
Award activity
THE EMMES COMPANY, LLC received an unusually large obligation action
Buyer demand
Reported obligations through NATIONAL INSTITUTES OF HEALTH NIAID increased
Competitive shifts
THE EMMES COMPANY, LLC had the largest increase in reported obligations
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Sep 10, 2026.
97.1% of positive obligations were attributed to NATIONAL INSTITUTES OF HEALTH NIAID. That represents $29.3M, up $1.9M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- NATIONAL INSTITUTES OF HEALTH NIAID97.1% · $29.3M · up $1.9M
- NATIONAL INSTITUTES OF HEALTH NHGRI1.1% · $345K · up $315K
- NATIONAL INSTITUTES OF HEALTH NIA0.76% · $229K · up $229K
- NATIONAL INSTITUTES OF HEALTH NIAAA0.57% · $173K · up $173K
- CDC OFFICE OF ACQUISITION SERVICES0.44% · $133K · up $920K
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
NATIONAL INSTITUTES OF HEALTH NIAID
#1Rank unchangedLatest 12 months
$29.3M
97.1% of positive obligations
Versus preceding 12 months
+$1.9M
4 active prime contractors · 7 awards
View office comparison and evidence
Reported obligations increased 7.0% from $27.4M to $29.3M. The office’s share of positive obligations moved from 97.4% to 97.1%, a change of −0.3 percentage points.
The latest period contains 15 actions across 7 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 12 awards.
Leading award-level changes
- THE EMMES COMPANY, LLC · PIID 75N93021C00012+$1.9M: $25.5M → $27.4M
- BATTELLE MEMORIAL INSTITUTE · PIID 75N93019F00131+$1.6M: $0 → $1.6M
Reported funding office
NATIONAL INSTITUTES OF HEALTH NHGRI
#2Up 3 from #5Latest 12 months
$345K
1.1% of positive obligations
Versus preceding 12 months
+$315K
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations increased 1042.0% from $30K to $345K. The office’s share of positive obligations moved from 0.11% to 1.1%, a change of +1.0 percentage points.
The latest period contains 2 actions across 1 award. The preceding period contained 2 active prime contractors and 2 awards.
Reported funding office
NATIONAL INSTITUTES OF HEALTH NIA
#3New to the positive-obligation rankingLatest 12 months
$229K
0.76% of positive obligations
Versus preceding 12 months
+$229K
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations rose from $0 to $229K. The office’s share of positive obligations moved from 0% to 0.76%, a change of +0.8 percentage points.
The latest period contains 2 actions across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.
Reported funding office
NATIONAL INSTITUTES OF HEALTH NIAAA
#4New to the positive-obligation rankingLatest 12 months
$173K
0.57% of positive obligations
Versus preceding 12 months
+$173K
1 active prime contractor · 2 awards
View office comparison and evidence
Reported obligations rose from $0 to $173K. The office’s share of positive obligations moved from 0% to 0.57%, a change of +0.6 percentage points.
The latest period contains 2 actions across 2 awards and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.
Reported funding office
CDC OFFICE OF ACQUISITION SERVICES
#5New to the positive-obligation rankingLatest 12 months
$133K
0.44% of positive obligations
Versus preceding 12 months
+$920K
4 active prime contractors · 4 awards
View office comparison and evidence
Reported obligations moved from $787K in net deobligations to $133K in net obligations. The office’s share of positive obligations moved from 0% to 0.44%, a change of +0.4 percentage points.
The latest period contains 6 actions across 4 awards and 2 newly active prime contractors. The preceding period contained 4 active prime contractors and 4 awards.
Reported funding office
NATIONAL INSTITUTES OF HEALTH
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$42K
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $42K to $0. The office’s share of positive obligations moved from 0.15% to 0%, a change of −0.1 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 1 active prime contractor and 1 award.
Reported funding office
OFC ASST SEC FOR PREPARENESS RES
No positive-obligation rankLatest 12 months
−$5K
0% of positive obligations
Versus preceding 12 months
−$5K
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations moved from $0 in net obligations to $5K in net deobligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.
The latest period contains 1 action across 1 award and 1 newly active prime contractor. The preceding period contained 0 active prime contractors and 0 awards.
Reported funding office
NATIONAL INSTITUTES OF HEALTH NHLBI
No positive-obligation rankLatest 12 months
−$14K
0% of positive obligations
Versus preceding 12 months
−$330K
1 active prime contractor · 3 awards
View office comparison and evidence
Reported obligations moved from $316K in net obligations to $14K in net deobligations. The office’s share of positive obligations moved from 1.1% to 0%, a change of −1.1 percentage points.
The latest period contains 3 actions across 3 awards. The preceding period contained 2 active prime contractors and 8 awards.
Reported funding office
NIH NCI
No positive-obligation rankLatest 12 months
−$71K
0% of positive obligations
Versus preceding 12 months
−$426K
2 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations moved from $355K in net obligations to $71K in net deobligations. The office’s share of positive obligations moved from 1.3% to 0%, a change of −1.3 percentage points.
The latest period contains 3 actions across 3 awards and 1 newly active prime contractor. The preceding period contained 2 active prime contractors and 2 awards.
Leading award-level changes
- METACLIPSE THERAPEUTICS CORP · PIID 75N91025C00038−$410K: $355K → −$55K
Reported funding office
BARDA - ASPR / DAAPPO / BARDA DCMA
No positive-obligation rankLatest 12 months
−$456K
0% of positive obligations
Versus preceding 12 months
−$27K
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations widened from $429K to $456K in net deobligations. The office’s share of positive obligations moved from 0% to 0%, a change of 0.0 percentage points.
The latest period contains 1 action across 1 award. The preceding period contained 2 active prime contractors and 3 awards.
Contract types, competition, and procurement methods
From Sep 11, 2025 through Sep 10, 2026, 8 awards had positive obligations totaling $30.2M. Negotiated Proposal/Quote was the leading reported procedure, accounting for 96.0% of positive obligations. Awards with a reported parent IDV accounted for 6.4%.
Limited sample: These figures describe 8 observed awards in this period and may not represent a stable buying pattern.
- Leading award type
- 90.7%
- Definitive Contract
- Leading reported procedure
- 96.0%
- Negotiated Proposal/Quote
- Reported parent IDV
- 6.4%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 6 of 8 awards reported offers
Same-NAICS comparison
Compared with the NAICS 541713 peer median, parent-IDV obligation share is 5.0 percentage points higher, reported full-and-open obligation share is 86.0 percentage points higher, delivery-order obligation share is 5.0 percentage points higher, and median positive award obligations are 26.3% lower.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 6.4% | 1.4% | +5.0 pts |
| Reported full-and-open obligation share | 96.0% | 10.0% | +86.0 pts |
| Delivery-order obligation share | 6.4% | 1.4% | +5.0 pts |
| Median positive award obligations | $335K | $454K | -26.3% |
Peer cohort and comparison limits
The peer median gives each of the 2 eligible agency markets equal weight. The included agency markets are:
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Definitive Contract(D) | 1 | $27.4M | 90.7% |
| Delivery Order(C) | 2 | $1.9M | 6.4% |
| Purchase Order(B) | 5 | $880K | 2.9% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 2 | $1.9M | 6.4% |
| Not reported | 6 | $28.3M | 93.6% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 2 | $1.9M | 6.4% |
| Not reported | 6 | $28.3M | 93.6% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Negotiated Proposal/Quote(NP) | 2 | $29.0M | 96.0% |
| Sp1(SIMPLIFIED ACQUISITION) | 3 | $663K | 2.2% |
| Np(NEGOTIATED PROPOSAL/QUOTE) | 1 | $335K | 1.1% |
| Simplified Acquisition(SP1) | 2 | $217K | 0.72% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Full and Open Competition(A) | 2 | $29.0M | 96.0% |
| G(NOT COMPETED UNDER SAP) | 1 | $345K | 1.1% |
| A(FULL AND OPEN COMPETITION) | 1 | $335K | 1.1% |
| F(COMPETED UNDER SAP) | 2 | $318K | 1.1% |
| Not Competed Under SAP(G) | 2 | $217K | 0.72% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Not reported | 8 | $30.2M | 100.0% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| SAP Non-Competition (FAR 13)(SP2) | 3 | $562K | 1.9% |
| Not reported | 5 | $29.7M | 98.1% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Cost Plus Fixed Fee(U) | 2 | $29.0M | 96.0% |
| J(FIRM FIXED PRICE) | 2 | $574K | 1.9% |
| U(COST PLUS FIXED FEE) | 2 | $424K | 1.4% |
| Firm Fixed Price(J) | 2 | $217K | 0.72% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Support- Management: Data Collection(R702) | 1 | $27.4M | 90.7% |
| Health R&d Services; Health Care Services; Applied Research(AN12) | 2 | $1.9M | 6.4% |
| in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550) | 1 | $345K | 1.1% |
| Laboratory Equipment and Supplies(6640) | 2 | $318K | 1.1% |
| Health R&d Services; Health Care - Other; Applied Research(AN42) | 1 | $133K | 0.44% |
| Drugs and Biologicals(6505) | 1 | $84K | 0.28% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| National Institutes of Health(7529) | 7 | $30.1M | 99.6% |
| Centers for Disease Control and Prevention(7523) | 1 | $133K | 0.44% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| National Institutes of Health Niaid(75N930) | 3 | $29.4M | 97.1% |
| National Institutes of Health Olao(75N980) | 4 | $747K | 2.5% |
| Cdc Office of Acquisition Services(75D301) | 1 | $133K | 0.44% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 75N93018D00013(7529) | 2 | $1.9M | 6.4% |
| Not reported | 6 | $28.3M | 93.6% |
Offers, award size, and timing
- Median reported offers
- 1 median
- 6 reported · 2 not reported
- Positive award obligations
- $335K median
- $133K–$345K middle 50%
- Reported performance period
- 364 days (~12 months) median
- 8 reported · 0 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Sep 10, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 1 of 4prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 90.8%of positive obligations in the last 12 months
- Leading four prime contractors
- 100.0%of positive obligations in the last 12 months
- Leading eight prime contractors
- 100.0%of positive obligations in the last 12 months
Based on $30.2M in positive obligations during the 12 months ending Sep 10, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Sep 11, 2024–Sep 10, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$27.4M
90.8%
Dollar movement
+$1.9M
vs. prior 12 months
Last 12mo awards
1 award
6 actions
Historical and award details for THE EMMES COMPANY, LLC
- Obligations: prior → latest
- $25.5M → $27.4M
- +7.3%
- Share: prior → latest
- 90.1% → 90.8%
- +0.7 percentage points
- All-period obligations
- $146.4M
- 62.8% of all-period positive obligations · 2 awards
- Recorded activity
- Since Oct 14, 2021
- through Aug 5, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$1.9M
6.3%
Dollar movement
−$12K
vs. prior 12 months
Last 12mo awards
4 awards
8 actions
Historical and award details for BATTELLE MEMORIAL INSTITUTE
- Obligations: prior → latest
- $1.9M → $1.9M
- −0.6%
- Share: prior → latest
- 6.7% → 6.3%
- −0.5 percentage points
- All-period obligations
- $28.0M
- 12.0% of all-period positive obligations · 18 awards
- Recorded activity
- Since Jan 26, 2022
- through Sep 8, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 4 8 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$747K
2.5%
Dollar movement
+$731K
vs. prior 12 months
Last 12mo awards
4 awards
6 actions
Historical and award details for OXFORD NANOPORE TECHNOLOGIES INC
- Obligations: prior → latest
- $16K → $747K
- +4612.3%
- Share: prior → latest
- 0.060% → 2.5%
- +2.4 percentage points
- All-period obligations
- $865K
- 0.37% of all-period positive obligations · 11 awards
- Recorded activity
- Since Jul 13, 2022
- through Aug 27, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 4 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$133K
0.44%
Dollar movement
+$133K
vs. prior 12 months
Last 12mo awards
1 award
2 actions
Historical and award details for THE REGENTS OF THE UNIVERSITY OF COLORADO
- Obligations: prior → latest
- $0 → $133K
- Not comparable
- Share: prior → latest
- 0% → 0.44%
- +0.4 percentage points
- All-period obligations
- $133K
- 0.060% of all-period positive obligations · 1 award
- Recorded activity
- Since Feb 12, 2026
- through Jun 9, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 0 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
−$456K
0%
Dollar movement
−$27K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for RIDGEBACK BIOTHERAPEUTICS LP
- Obligations: prior → latest
- −$429K → −$456K
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- $4.0M
- 1.7% of all-period positive obligations · 2 awards
- Recorded activity
- Since Oct 29, 2021
- through Jun 10, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 2 Not reported 0 0 Reported small business 1 2 All-period set-aside types
None reported.
- #6
Last 12mo obligations
−$55K
0%
Dollar movement
−$410K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for METACLIPSE THERAPEUTICS CORP
- Obligations: prior → latest
- $355K → −$55K
- Not comparable
- Share: prior → latest
- 1.3% → 0%
- −1.3 percentage points
- All-period obligations
- $300K
- 0.13% of all-period positive obligations · 1 award
- Recorded activity
- Since Sep 4, 2025
- through Aug 11, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 1 1 Reported no set-aside 0 0 Not reported 0 0 Reported small business 1 1 All-period set-aside types
- 1 · Total small business
- #7
Last 12mo obligations
−$16K
0%
Dollar movement
−$16K
vs. prior 12 months
Last 12mo awards
2 awards
2 actions
Historical and award details for DEPARTMENT OF HEALTH
- Obligations: prior → latest
- $0 → −$16K
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- −$16K
- 0% of all-period positive obligations · 2 awards
- Recorded activity
- Since Jul 29, 2026
- through Jul 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 0 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
−$14K
0%
Dollar movement
−$364K
vs. prior 12 months
Last 12mo awards
3 awards
3 actions
Historical and award details for TRUSTEES OF INDIANA UNIVERSITY
- Obligations: prior → latest
- $350K → −$14K
- Not comparable
- Share: prior → latest
- 1.2% → 0%
- −1.2 percentage points
- All-period obligations
- $3.6M
- 1.5% of all-period positive obligations · 10 awards
- Recorded activity
- Since Dec 6, 2021
- through Jan 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 3 6 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
−$5K
0%
Dollar movement
−$5K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for WAKE FOREST UNIVERSITY HEALTH SCIENCES
- Obligations: prior → latest
- $0 → −$5K
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- $16.8M
- 7.2% of all-period positive obligations · 1 award
- Recorded activity
- Since Oct 19, 2021
- through Jul 28, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #10
Last 12mo obligations
−$512
0%
Dollar movement
−$512
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for SOMALOGIC OPERATING CO., INC
- Obligations: prior → latest
- $0 → −$512
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- −$512
- 0% of all-period positive obligations · 1 award
- Recorded activity
- Since Aug 28, 2026
- through Aug 28, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 0 Not reported 0 0 Reported small business 1 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
−$317
0%
Dollar movement
+$5K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for HEALTH RESEARCH, INC.
- Obligations: prior → latest
- −$5K → −$317
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- $4.9M
- 2.1% of all-period positive obligations · 1 award
- Recorded activity
- Since Oct 14, 2021
- through Sep 1, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$0
0%
Dollar movement
$0
no change vs. prior 12 months
Last 12mo awards
1 award
2 actions
Historical and award details for PRO-CHANGE BEHAVIOR SYSTEMS, INC.
- Obligations: prior → latest
- $0 → $0
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- $1.5M
- 0.62% of all-period positive obligations · 1 award
- Recorded activity
- Since Sep 25, 2023
- through Jun 9, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 0 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$0
0%
Dollar movement
$0
no change vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for FORS MARSH GROUP LLC
- Obligations: prior → latest
- $0 → $0
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- $650K
- 0.28% of all-period positive obligations · 1 award
- Recorded activity
- Since Sep 21, 2023
- through Jun 9, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$0
0%
Dollar movement
$0
no change vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for OHIO STATE UNIVERSITY, THE
- Obligations: prior → latest
- $0 → $0
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- $248K
- 0.11% of all-period positive obligations · 2 awards
- Recorded activity
- Since Jun 16, 2022
- through Jun 9, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #15NANOBIOSYM INCHistorical · no latest 12-month activity · last action May 5, 2025
Last 12mo obligations
$0
0%
Dollar movement
$0
no change vs. prior 12 months
Last 12mo awards
0 awards
0 actions
Historical and award details for NANOBIOSYM INC
- Obligations: prior → latest
- $0 → $0
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- $14.6M
- 6.3% of all-period positive obligations · 1 award
- Recorded activity
- Since Sep 27, 2022
- through May 5, 2025
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
Potential federal contract recompetes
Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.
THE EMMES COMPANY, LLC
SDCC
$176.6M is obligated on an award with a reported potential end date of February 29, 2028.
Performance period
79.0%
Current award value as a share of potential value
60.0%
Supporting data
Reported performance starts Mar 1, 2021.
Current performance is reported through Feb 28, 2027.
$176.6M is obligated against $176.6M in current reported award value (100.0%).
Reported potential end dates: Feb 28, 2022 → Feb 28, 2023 → Feb 29, 2028.
Obligations are compared with current reported award value, not treated as a contract ceiling.
These are research leads, not confirmed recompetes. USAspending records through Sep 10, 2026; reported dates and values can change through later modifications.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$18.9M
THE EMMES COMPANY, LLC
NATIONAL INSTITUTES OF HEALTH NIAID
SDCC
Why it stands out
One action equaled at least half of the market’s latest 12-month positive obligations.
The $18.9M action represented 62.5% of the market’s positive obligations over the latest 12 months.
- Award net obligations
- $176.6M
- Share of 12-month positive obligations
- 62.5%
Supporting data
- Prime contractor
- #1 · 90.8% share
- +0.7 percentage points · $1.9M net increase; action exceeded it by $17.0M
- Funding office
- #1 · 97.1% attributed share
- −0.3 percentage points · $1.9M net increase; action exceeded it by $17.0M
This action
+$2.7M
BATTELLE MEMORIAL INSTITUTE
NATIONAL INSTITUTES OF HEALTH NIAID
BATTELLE MEMORIAL INSTITUTE; IMMUNOGENICITY AND EFFICACY TESTING OF MEDICAL COUNTERMEASURES (VACCINES AND OTHER BIOLOGICS) AGAINST BSL-4 PATHOGENS IN NHPS; TO 2
Why it stands out
One action represented 8.9% of the market’s latest 12-month positive obligations.
At $2.7M, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $9.3M
- Share of 12-month positive obligations
- 8.9%
Supporting data
- Prime contractor
- #2 · 6.3% share
- $12K net decline despite this positive action
This action
−$456K
RIDGEBACK BIOTHERAPEUTICS LP
BARDA - ASPR / DAAPPO / BARDA DCMA
THIS MODIFICATION DE-OBLIGATES CANCELING YEAR FUNDS FROM REQUISITION OS251050 IN THE AMOUNT OF $(200,285.24) AND FROM REQUISITION OS272235 IN THE AMOUNT OF $(255,619.91) FROM BASE/CLIN0001. THE CONTRACT TOTAL AMOUNT IS DECREASED BY $(455,905.15)
Why it stands out
This award recorded a material contraction.
The action removed $456K. A deobligation does not by itself show lower requirement demand.
- Award net obligations
- $19.3M
- Share of 12-month positive obligations
- 1.5%
This action
+$345K
OXFORD NANOPORE TECHNOLOGIES INC
NATIONAL INSTITUTES OF HEALTH NHGRI
NHGRI: 1. PROMETHION FLOW CELLS PACKS (RNA) 2. PROMETHION FLOW CELLS PACKS (DNA) 3. DIRECT RNA SEQUENCING KIT XL 4. DIRECT RNA BARCODING KIT 24 5. ULTRA-LONG DNA SEQUENCING KIT V14 6. LIGATION SEQUENCING KIT XL V14 7. RAPID SEQUENCING KIT V14
Why it stands out
The contractor climbed 4 positions in this market.
It now ranks #3 by positive obligations over the latest 12 months.
- Award net obligations
- $345K
- Share of 12-month positive obligations
- 1.1%
Supporting data
- Prime contractor
- #3 · 2.5% share
- up 4 ranks · +2.4 percentage points · $731K net increase; action accounted for 47.2%
- Funding office
- #2 · 1.1% attributed share
- up 3 ranks · +1.0 percentage points · $315K net increase; action exceeded it by $30K
This action
+$229K
OXFORD NANOPORE TECHNOLOGIES INC
NATIONAL INSTITUTES OF HEALTH NIA
NIA: SUPPLY: LONG SEQUENCING KITS: N/A
Why it stands out
The contractor climbed 4 positions in this market.
It now ranks #3 by positive obligations over the latest 12 months.
- Award net obligations
- $229K
- Share of 12-month positive obligations
- 0.76%
Supporting data
- Funding office
- #3 · 0.76% attributed share
- +0.8 percentage points · $229K net increase; action accounted for 100.0%
This action
+$133K
THE REGENTS OF THE UNIVERSITY OF COLORADO
CDC OFFICE OF ACQUISITION SERVICES
CDC AFM CASE CLASSIFICATION
Why it stands out
No activity for this contractor was reported in this market during the preceding 12 months.
The base action placed the contractor #4 in this market by positive obligations over the latest 12 months.
- Award net obligations
- $133K
- Share of 12-month positive obligations
- 0.44%
Supporting data
- Prime contractor
- #4 · 0.44% share
- Newly active in this market; no actions were reported in the preceding 12 months
- Funding office
- #5 · 0.44% attributed share
- +0.4 percentage points · $920K net increase; action accounted for 14.5%
View recent award activity by date (10)
- Action−$172Award net obligations$870K
- Action−$317Award net obligations$10.3M
- Action−$512Award net obligations$75K
- Action+$89KAward net obligations$89K
- Action−$55KAward net obligations$300K
- Action−$45KAward net obligations$176.6M
- Action+$345KAward net obligations$345K
- Action−$15KAward net obligations$0
- Action−$600Award net obligations$173K
- Action−$5KAward net obligations$31.3M
HHS research and development in nanotechnology market FAQs
Answers based on reported federal contract data.
Who are the top HHS research and development in nanotechnology contractors?
In the 12 months through September 10, 2026, THE EMMES COMPANY, LLC, BATTELLE MEMORIAL INSTITUTE, and OXFORD NANOPORE TECHNOLOGIES INC were the leading HHS research and development in nanotechnology prime contractors by positive obligations.
- #1
$27,418,035 in positive obligations
- #2
$1,896,281 in positive obligations
- #3
OXFORD NANOPORE TECHNOLOGIES INC
$746,990 in positive obligations
Rankings use reported USAspending award data.
Did HHS contract obligations increase in the research and development in nanotechnology market?
Yes. Measured by net prime contract obligations, reported HHS activity in the research and development in nanotechnology market increased 10.1% from $26,934,119 in the preceding 12 months to $29,647,289 in the 12 months through September 10, 2026.
- Latest 12 months
- $29,647,289
- Net prime contract obligations
- Preceding 12 months
- $26,934,119
- Net prime contract obligations
- Change
- +10.1%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent HHS contract award activity was reported in the research and development in nanotechnology market?
Recent HHS contract award activity reported in the research and development in nanotechnology market included actions for THE EMMES COMPANY, LLC, BATTELLE MEMORIAL INSTITUTE, and RIDGEBACK BIOTHERAPEUTICS LP during the 12 months through September 10, 2026.
-
THE EMMES COMPANY, LLC · PIID 75N93021C00012
Modification P00017 · January 29, 2026 · Action obligation: +$18,868,858
-
BATTELLE MEMORIAL INSTITUTE · PIID 75N93019F00131
Modification P00010 · December 15, 2025 · Action obligation: +$2,688,967
-
RIDGEBACK BIOTHERAPEUTICS LP · PIID 75A50120C00009
Deobligation P00016 · June 10, 2026 · Action obligation: -$455,905
-
OXFORD NANOPORE TECHNOLOGIES INC · PIID 75N98026P01150
Base award · July 30, 2026 · Action obligation: +$345,390
-
OXFORD NANOPORE TECHNOLOGIES INC · PIID 75N98026P01053
Base award · July 17, 2026 · Action obligation: +$228,645
-
THE REGENTS OF THE UNIVERSITY OF COLORADO · PIID 75D30126P20754
Base award · February 12, 2026 · Action obligation: +$132,999
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for HHS contracts under NAICS 541713?
From September 11, 2025 through September 10, 2026, HHS reported 8 positive-obligation awards for research and development in nanotechnology under NAICS 541713. The leading award type was definitive contract. The leading reported procedure was negotiated proposal/quote.
- Positive-obligation awards
- 8
- Leading reported procedure
- Negotiated Proposal/Quote
- 96% of positive obligations
- Leading award type
- Definitive Contract
- 90.7% of positive obligations
- Full and open
- 96%
- of positive obligations
- Reported parent IDV
- 6.4%
- of positive obligations
Limited sample: 8 positive-obligation awards. Percentages use positive obligations as the denominator.
Which HHS research and development in nanotechnology awards may warrant recompete research?
Based on its reported potential-end date, the HHS research and development in nanotechnology award held by THE EMMES COMPANY, LLC may warrant recompete research.
-
THE EMMES COMPANY, LLC · PIID 75N93021C00012
Potential end: February 29, 2028
Research leads, not confirmed recompetes. Dates may change through later modifications.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Reported obligations include contract actions from October 1, 2021 through September 10, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.
Review data methodology